eDruginfo.com
Wolters Kluwer | Lippencott Williams & Wilkins
Drug Updates | New Indications

   Drug Updates
       New Drugs
       New Indications
   Patient Teaching

   News Capsules

   Drug Warnings

   Herbal Spotlight

   Quik Tools

   Drug Info Links

   Drug Info Bookstore

   Feedback

   Registration

   Disclaimer



irbesartan hydrochlorothiazide
Avalide Pharmaceutical company:
Sanofi-Aventis
www.sanofi-aventis.us

NEW INDICATION & DOSAGE
Initial therapy in patients likely to need multiple drugs to achieve blood pressure control--
Adults: Initially, 150 mg irbesartan and 12.5 mg hydrochlorothiazide P.O. once daily for 1 to 2 weeks. Adjust as needed to a maximum of 300 mg irbesartan and 25 mg hydrochlorothiazide P.O. per day.

     
   

Home - Guest Registry - Customer Service

Brought to you by Lippincott Williams & Wilkins.
For help on how you should use this site, see our
Disclaimer .

© Copyright 2008 by Lippincott Williams & Wilkins